T-bet acts as a powerful adjuvant in Ag85B DNA-based vaccination against tuberculosis

Molecular Medicine Reports

Volumn 6, Issue 1, 2012, Pages 139-144

  Hu, Dong ^a   Wu, Jing ^a   Zhang, Rongbo ^a   Chen, Liping ^a  

^a ANHUI UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Adjuvants; Ag85B; Cytokines; Mycobacterium tuberculosis; T bet; Vaccine

Indexed keywords

DNA VACCINE; GAMMA INTERFERON; IMMUNOGLOBULIN G2A ANTIBODY; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 2; PLASMID DNA; T BET AG85B DNA VACCINE; TRANSCRIPTION FACTOR T BET; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; FEMALE; IMMUNOGENICITY; INFECTION PREVENTION; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; TH1 CELL; TUBERCULOSIS;

ACYLTRANSFERASES; ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODY SPECIFICITY; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CELL LINE; CYTOKINES; FEMALE; HUMANS; LUNG; MICE; MICE, INBRED BALB C; PLASMIDS; SPLEEN; T-BOX DOMAIN PROTEINS; TUBERCULOSIS; TUBERCULOSIS VACCINES; VACCINES, DNA;

MUS; MYCOBACTERIUM BOVIS BCG; MYCOBACTERIUM TUBERCULOSIS;

EID: 84861585692     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2012.883     Document Type: Article

References (23)

1. Józefowski S, Sobota A and Kwiatkowska K: How Mycobacterium tuberculosis subverts host immune responses. Bioessays 30: 943-954, 2008.
2. Pai M, Zwerling A and Menzies D: Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 149: 177-184, 2008.
3. Orme IM, Andersen P and Boom WH: T cell response to Mycobacterium tuberculosis. J Infect Dis 167: 1481-1497, 1993. (Pubitemid 23146211)
4. Orme IM: Current progress in tuberculosis vaccine development. Vaccine 23: 2105-2108, 2005.
5. Palma C, Iona E, Giannoni F, Pardini M, Brunori L, Orefici G, et al: The Ag85B protein of Mycobacterium tuberculosis may turn a protective immune response induced by Ag85B-DNA vaccine into a potent but non-protective Th1 immune response in mice. Cell Microbiol 9: 1455-1465, 2007.
6. Doherty TM, Olsen AW, Weischenfeldt J, Huygen K, D'Souza S, Kondratieva TK, et al: Comparative analysis of different vaccine constructs expressing defined antigens from Mycobacterium tuberculosis. J Infect Dis 190: 2146-2153, 2004. (Pubitemid 39636362)
7. Kamath AT, Feng CG, Macdonald M, Briscoe H and Britton WJ: Differential protective efficacy of DNA vaccines expressing secreted proteins of Mycobacterium tuberculosis. Infect Immun 67: 1702-1707, 1999. (Pubitemid 29144386)
8. Olsen AW, Williams A, Okkels LM, Hatch G and Andersen P: Protective effect of a tuberculosis subunit vaccine based on a fusion of antigen 85B and ESAT-6 in the aerosol guinea pig model. Infect Immun 72: 6148-6150, 2004. (Pubitemid 39303732)
9. Palendira U, Spratt JM, Britton WJ and Triccas JA: Expanding the antigenic repertoire of BCG improves protective efficacy against aerosol Mycobacterium tuberculosis infection. Vaccine 23: 1680-1685, 2005. (Pubitemid 40215701)
10. Glimcher LH: Trawling for treasure: tales of T-bet. Nat Immunol 8: 448-450, 2007.
11. Alcaide P, Jones TG, Lord GM, Glimcher LH, Hallgren J, Arinobu Y, et al: Dendritic cell expression of the transcription factor T-bet regulates mast cell progenitor homing to mucosal tissue. J Exp Med 204: 431-439, 2007. (Pubitemid 46294557)
12. Peng SL: The T-box transcription factor T-bet in immunity and autoimmunity. Cell Mol Immunol 3: 87-95, 2006.
13. Martins GA, Hutchins AS and Reiner SL: Transcriptional activators of helper T cell fate are required for establishment but not maintenance of signature cytokine expression. J Immunol 175: 5981-5985, 2005. (Pubitemid 41508083)
14. Hu D, Wu J, Hu F, Yang Y, Liang C, Chen J, et al: Stage and tissue specific differences in SjBMI1, a Polycomb protein in Schistosoma japonicum. Parasitol Res 106: 677-682, 2010.
15. Hu D, Wu J, Tang X, Hu F, Yang Y, Du J, et al: Molecular cloning and tissue distribution of a Schistosoma japonicum gene encoding AMY-1. Mol Med Report 4: 1267-1271, 2011.
16. Wu J, Hu D, Yang G, Zhou J, Yang C, Gao Y and Zhu Z: Down-regulation of BMI-1 cooperates with artemisinin on growth inhibition of nasopharyngeal carcinoma cells. J Cell Biochem 112: 1938-1948, 2011.
17. Chen J, Hu X, He S, Wang L, Hu D, Wang X, et al: Expression and immune response analysis of Schistosoma japonicum VAL-1, a homologue of vespid venom allergens. Parasitol Res 106: 1413-1418, 2010.
18. Wu J, Hu D, Du JW, Tao XR, Qi XL and Zhang RB: Th1 immunity is not required for the effect of lipopolysaccharide exposure on modifying asthmatic responses of mice before sensitization. Chin Med J (Engl) 123: 1047-1051, 2010.
19. Hoft DF: Tuberculosis vaccine development: goals, immunological design, and evaluation. Lancet 372: 164-175, 2008.
20. Quesniaux VF, Jacobs M, Allie N, Grivennikov S, Nedospasov SA, Garcia I, et al: TNF in host resistance to tuberculosis infection. Curr Dir Autoimmun 11: 157-179, 2010.
21. Fan X, Gao Q and Fu R: Differential immunogenicity and protective efficacy of DNA vaccines expressing proteins of Mycobacterium tuberculosis in a mouse model. Microbiol Res 164: 374-382, 2009.
22. Taylor JL, Turner OC, Basaraba RJ, Belisle JT, Huygen K and Orme IM: Pulmonary necrosis resulting from DNA vaccination against tuberculosis. Infect Immun 71: 2192-2198, 2003. (Pubitemid 36368754)
23. Turner J, Rhoades ER, Keen M, Belisle JT, Frank AA and Orme IM: Effective preexposure tuberculosis vaccines fail to protect when they are given in an immunotherapeutic mode. Infect Immun 68: 1706-1709, 2000. (Pubitemid 30108577)